Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 661

1.

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy.

Kim HS, Lee JS, Lee HK, Park EJ, Jeon HW, Kang YJ, Lee TY, Kim KS, Bae SC, Park JH, Han SB.

Immune Netw. 2019 Oct 14;19(5):e36. doi: 10.4110/in.2019.19.e36. eCollection 2019 Oct.

PMID:
31720047
2.

Associations between paraoxonase-1 and systemic lupus erythematosus.

Bae SC, Lee YH.

Lupus. 2019 Nov;28(13):1571-1576. doi: 10.1177/0961203319884653. Epub 2019 Oct 25.

PMID:
31653192
3.

Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Oct 21. doi: 10.1002/art.41144. [Epub ahead of print]

PMID:
31631584
4.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2019 Oct 17:102340. doi: 10.1016/j.jaut.2019.102340. [Epub ahead of print]

5.

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE.

Arthritis Care Res (Hoboken). 2019 Oct 14. doi: 10.1002/acr.24092. [Epub ahead of print]

PMID:
31609532
6.
7.

Implementation of Combinatorial Genetic and Microenvironmental Engineering to Microbial-Based Field-Deployable Microbead Biosensors for Highly Sensitive and Remote Chemical Detection.

Lee K, Choi S, Kim C, Kang WS, Son W, Bae SC, Oh JW, Lee SK, Cha C.

ACS Sens. 2019 Oct 25;4(10):2716-2723. doi: 10.1021/acssensors.9b01183. Epub 2019 Sep 25.

PMID:
31512857
8.

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis.

Gu KN, Bang SY, Lee HS, Park Y, Kang JY, Kim JS, Nam B, Yoo HS, Shin JM, Lee YK, Lee TH, Chun S, Cho SK, Choi CB, Sung YK, Kim TH, Jun JB, Yoo DH, Kim K, Bae SC.

Arthritis Res Ther. 2019 Aug 28;21(1):195. doi: 10.1186/s13075-019-1983-y.

10.

Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project.

Manzi S, Raymond S, Tse K, Peña Y, Anderson A, Arntsen K, Bae SC, Bruce I, Dörner T, Getz K, Hanrahan L, Kao A, Morand E, Rovin B, Schanberg LE, Von Feldt JM, Werth VP, Costenbader K.

Lupus Sci Med. 2019 Jul 19;6(1):e000342. doi: 10.1136/lupus-2019-000342. eCollection 2019.

11.

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.

Sung YK, Yoshida K, Prince FHM, Frits ML, Cho SK, Choe JY, Lee HS, Lee J, Lee SS, Yoo DH, Helfgott SM, Shadick NA, Weinblatt ME, Solomon DH, Bae SC.

PLoS One. 2019 Aug 14;14(8):e0221314. doi: 10.1371/journal.pone.0221314. eCollection 2019.

12.

Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Svenungsson E, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2019 Aug 7. doi: 10.1002/art.41070. [Epub ahead of print]

PMID:
31390162
13.

Causal relationship between years of education and the occurrence of rheumatoid arthritis.

Bae SC, Lee YH.

Postgrad Med J. 2019 Jul;95(1125):378-381. doi: 10.1136/postgradmedj-2018-136374. Epub 2019 May 24.

PMID:
31127051
14.

Cochlear Implant Surgery Through Round Window Approach Is Always Possible.

Bae SC, Shin YR, Chun YM.

Ann Otol Rhinol Laryngol. 2019 Jun;128(6_suppl):38S-44S. doi: 10.1177/0003489419834311.

PMID:
31092036
15.

Increased risk of opportunistic infection in early rheumatoid arthritis.

Kim H, Cho SK, Lee J, Bae SC, Sung YK.

Int J Rheum Dis. 2019 Jul;22(7):1239-1246. doi: 10.1111/1756-185X.13585. Epub 2019 May 14.

PMID:
31090187
16.

Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.

Molineros JE, Looger LL, Kim K, Okada Y, Terao C, Sun C, Zhou XJ, Raj P, Kochi Y, Suzuki A, Akizuki S, Nakabo S, Bang SY, Lee HS, Kang YM, Suh CH, Chung WT, Park YB, Choe JY, Shim SC, Lee SS, Zuo X, Yamamoto K, Li QZ, Shen N, Porter LL, Harley JB, Chua KH, Zhang H, Wakeland EK, Tsao BP, Bae SC, Nath SK.

PLoS Genet. 2019 Apr 25;15(4):e1008092. doi: 10.1371/journal.pgen.1008092. eCollection 2019 Apr.

17.

Association between the interferon regulatory factor 5 rs2004640 functional polymorphism and systemic lupus erythematosus: an updated meta-analysis.

Bae SC, Lee YH.

Lupus. 2019 May;28(6):740-747. doi: 10.1177/0961203319844014. Epub 2019 Apr 24.

PMID:
31018759
18.

RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point.

Lee JW, Kim DM, Jang JW, Park TG, Song SH, Lee YS, Chi XZ, Park IY, Hyun JW, Ito Y, Bae SC.

Nat Commun. 2019 Apr 23;10(1):1897. doi: 10.1038/s41467-019-09810-w.

19.

Prevalence and predictors for sustained remission in rheumatoid arthritis.

Sung YK, Yoshida K, Prince FHM, Frits ML, Cho SK, Choe JY, Lee HS, Lee J, Lee SS, Yoo DH, Helfgott SM, Shadick NA, Weinblatt ME, Solomon DH, Bae SC.

PLoS One. 2019 Apr 19;14(4):e0214981. doi: 10.1371/journal.pone.0214981. eCollection 2019. Erratum in: PLoS One. 2019 Aug 14;14(8):e0221314.

20.

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338. [Epub ahead of print]

PMID:
30988130
21.

Runx3 inhibits endothelial progenitor cell differentiation and function via suppression of HIF-1α activity.

Choo SY, Yoon SH, Lee DJ, Lee SH, Li K, Koo IH, Lee W, Bae SC, Lee YM.

Int J Oncol. 2019 Apr;54(4):1327-1336. doi: 10.3892/ijo.2019.4713. Epub 2019 Feb 11.

PMID:
30968151
22.
23.

Development of a Paper-Based Viscometer for Blood Plasma Using Colorimetric Analysis.

Kang H, Jang I, Song S, Bae SC.

Anal Chem. 2019 Apr 2;91(7):4868-4875. doi: 10.1021/acs.analchem.9b00624. Epub 2019 Mar 18.

PMID:
30848879
24.

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Aug;71(8):1297-1307. doi: 10.1002/art.40859. Epub 2019 May 29.

PMID:
30771242
25.

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.

Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón G, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet E.

Rheumatology (Oxford). 2019 Jul 1;58(7):1259-1267. doi: 10.1093/rheumatology/kez014.

PMID:
30753683
26.

Understanding HLA associations from SNP summary association statistics.

Lim J, Bae SC, Kim K.

Sci Rep. 2019 Feb 4;9(1):1337. doi: 10.1038/s41598-018-37840-9.

27.

Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study.

Bae SC, Lee YH.

Eur J Clin Invest. 2019 Apr;49(4):e13076. doi: 10.1111/eci.13076. Epub 2019 Feb 18.

PMID:
30710354
28.

Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values.

Chung MK, Park B, Kim IJ, Cho SK, Kim D, Sung YK, Choi CB, Choe JY, Chung WT, Hong SJ, Kim TH, Koh E, Lee SS, Yoon BY, Park H, Bae SC, Lee J.

Int J Rheum Dis. 2019 May;22(5):852-859. doi: 10.1111/1756-185X.13469. Epub 2019 Jan 24.

PMID:
30677239
29.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

30.

Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea.

Song JJ, Song YW, Bae SC, Cha HS, Choe JY, Choi SJ, Kim HA, Kim J, Kim SS, Lee CK, Lee J, Lee SH, Lee SS, Lee SK, Lee SW, Park SH, Park W, Shim SC, Suh CH, Yoo B, Yoo DH, Yoo WH.

J Korean Med Sci. 2018 Dec 18;33(52):e346. doi: 10.3346/jkms.2018.33.e346. eCollection 2018 Dec 24.

32.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2019 Jul;78(7):1010-1012. doi: 10.1136/annrheumdis-2018-214434. Epub 2018 Dec 20. No abstract available.

33.

Alcohol intake and risk of systemic lupus erythematosus: a Mendelian randomization study.

Bae SC, Lee YH.

Lupus. 2019 Feb;28(2):174-180. doi: 10.1177/0961203318817832. Epub 2018 Dec 12.

PMID:
30539684
34.

Functional relationship between p53 and RUNX proteins.

Bae SC, Kolinjivadi AM, Ito Y.

J Mol Cell Biol. 2019 Mar 1;11(3):224-230. doi: 10.1093/jmcb/mjy076.

35.

High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis.

Lee JS, Ahmad H, Shim SC, Bae SC, Song YW, Lee EY.

Patient. 2019 Jun;12(3):319-326. doi: 10.1007/s40271-018-0347-z.

36.

Relationship between cerebral microbleeds and white matter MR hyperintensities in systemic lupus erythematosus: a retrospective observational study.

Yeoh H, Lee JY, Lee YJ, Park DW, Kim TY, Ahn GY, Bae SC, Kim YS, Kim HY, Kim CK, Kim JY, Kim H, Han JW.

Neuroradiology. 2019 Mar;61(3):265-274. doi: 10.1007/s00234-018-2130-1. Epub 2018 Nov 10.

PMID:
30415319
37.

Development of the Asia Pacific Lupus Collaboration cohort.

Kandane-Rathnayake R, Golder V, Louthrenoo W, Luo SF, Jan Wu YJ, Li Z, An Y, Lateef A, Sockalingam S, Navarra SV, Zamora L, Hamijoyo L, Katsumata Y, Harigai M, Chan M, O'Neill S, Goldblatt F, Hao Y, Zhang Z, Al-Saleh J, Khamashta M, Takeuchi T, Tanaka Y, Bae SC, Lau CS, Hoi A, Nikpour M, Morand EF.

Int J Rheum Dis. 2019 Mar;22(3):425-433. doi: 10.1111/1756-185X.13431. Epub 2018 Nov 5.

PMID:
30398013
38.

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2019 Feb;71(2):281-289. doi: 10.1002/art.40764. Epub 2019 Jan 18.

39.

Alcohol intake and risk of rheumatoid arthritis: a Mendelian randomization study.

Bae SC, Lee YH.

Z Rheumatol. 2019 Oct;78(8):791-796. doi: 10.1007/s00393-018-0537-z.

PMID:
30209555
41.

Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study.

Bae SC, Lee YH.

Clin Rheumatol. 2018 Oct;37(10):2875-2879. doi: 10.1007/s10067-018-4278-9. Epub 2018 Aug 30.

PMID:
30167974
42.

CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Faslpr mice.

Lee JH, Lee HK, Kim HS, Kim JS, Ji AY, Lee JS, Kim KS, Lee TY, Bae SC, Kim Y, Hong JT, Han SB.

Lupus. 2018 Oct;27(11):1854-1859. doi: 10.1177/0961203318794871. Epub 2018 Aug 23.

PMID:
30139297
43.

Meta-analysis of gene expression profiles of peripheral blood cells in systemic lupus erythematosus.

Bae SC, Lee YH.

Cell Mol Biol (Noisy-le-grand). 2018 Jul 30;64(10):40-49.

PMID:
30084812
44.
45.

Effect of a Combination of Prednisone or Mycophenolate Mofetil and Mesenchymal Stem Cells on Lupus Symptoms in MRL.Faslpr Mice.

Lee HK, Kim KH, Kim HS, Kim JS, Lee JH, Ji A, Kim KS, Lee TY, Chang IY, Bae SC, Hong JT, Kim Y, Han SB.

Stem Cells Int. 2018 Jul 3;2018:4273107. doi: 10.1155/2018/4273107. eCollection 2018.

46.

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902. doi: 10.1002/acr.23712. Epub 2019 Jun 12.

PMID:
30044551
47.
48.

Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients.

Kim JS, Kim D, Joo YB, Won S, Lee J, Shin J, Bae SC.

Lupus. 2018 Oct;27(11):1769-1777. doi: 10.1177/0961203318788163. Epub 2018 Jul 20.

PMID:
30028258
49.

Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study.

Park DJ, Kang JH, Lee KE, Bae SC, Chung WT, Choe JY, Jung SY, Kim YS, Lee HS, Lee J, Lee YA, Park SH, Park YJ, Suh CH, Yoo DH, Lee SS.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):89-96. Epub 2018 Jun 14.

50.

Causal association between rheumatoid arthritis and a decreased risk of Alzheimer's disease : A Mendelian randomization study.

Bae SC, Lee YH.

Z Rheumatol. 2019 May;78(4):359-364. doi: 10.1007/s00393-018-0504-8.

PMID:
29974225

Supplemental Content

Support Center